Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10383878 Anti-HER3 antibody-drug conjugate

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
October 4, 2016
Date of Patent
August 20, 2019
Patent Application Number
15285156
Patent Citations Received
‌
US Patent 11945882 Method for producing antibody-drug conjugate
0
‌
US Patent 11008398 Anti-TROP2 antibody-drug conjugate
‌
US Patent 11634508 Peptide conjugates of cytotoxins as therapeutics
0
‌
US Patent 11261261 Method of treating cancer comprising administration of anti-HER2 antibody-drug conjugate
‌
US Patent 11273155 Combination of antibody-drug conjugate and immune checkpoint inhibitor
‌
US Patent 11318212 Method for producing antibody-drug conjugate
0
‌
US Patent 11446386 Anti-CDH6 antibody and method of producing an anti-CDH6 antibody-drug conjugate
0
‌
US Patent 11872289 Anti-MUC1 antibody-drug conjugate
0
‌
US Patent 11555019 Peptide conjugates of microtubule-targeting agents as therapeutics
‌
US Patent 11584800 Method of treating cancer comprising administration of anti-HER2 antibody-drug conjugate
Patent Inventor Names
Reimar Abraham
0
Suguru Ueno
0
Thore Hettmann
0
Sabine Blum
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10383878
Patent Primary Examiner
‌
Sheela J. Huff

Find more entities like US Patent 10383878 Anti-HER3 antibody-drug conjugate

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo